SeDeM expert system a new innovator tool to develop pharmaceutical forms

被引:41
作者
Edward Aguilar-Diaz, Johnny [1 ,2 ]
Garcia-Montoya, Encarna [2 ]
Perez-Lozano, Pilar [2 ]
Maria Sune-Negre, Jose [2 ]
Minarro, Montserrat [2 ]
Tico, Jose Ramon [2 ]
机构
[1] Novartis Vaccines & Diagnost AG, Global Qual Operat Management, Basel, Switzerland
[2] Univ Barcelona, Pharm & Pharmaceut Technol Dept, E-08028 Barcelona, Spain
关键词
Computer-aided drug design; direct compression; drug development; oral drug delivery; orodispersible tablet; DISINTEGRATING TABLETS; FORMULATION; DIAGRAM;
D O I
10.3109/03639045.2012.756007
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Context: The SeDeM expert system is based on the experimental study and quantitative determination of the characterization parameters of powdered substances, the aim being to determine whether a substance is suitable for producing tablets by means of direct compression ( DC) technology, thereby reducing the lead time for pre-formulation studies. Additionally, this expert system also provides formulations with a minimum number of excipients. Objective: We used this system to analyze suitable formulas for the production of orodispersible ibuprofen tablets. Method: Twenty-one disintegrants and ibuprophen were characterized using SeDeM methodology. Results: The results indicated that production of ibuprofen tablets by DC would require improvements in the dimension and compressibility factors of the active pharmaceutical ingredient. The expert system analysis provided the specific percentage of disintegrant needed to blend with ibuprofen and a standardized formula of lubricants in order to obtain a powder mix that would successfully produce tablets by DC. The eight formulas proposed by SeDeM were produced and tested in the laboratory. Conclusion: All eight formulas successfully produced tablets by DC, but only four of them could be considered suitable for use as an orodispersible tablet and accomplishes all the pharmaceutical quality parameters. So, in fact, the use of the SeDeM system reduced the time of medicine's development and therefore the cost of the activity.
引用
收藏
页码:222 / 236
页数:15
相关论文
共 32 条
[1]  
Aguilar-Diaz JE, 2008, 6 WORLD M PHARM BIOP
[2]  
[Anonymous], 2011, EUR PHARM
[3]  
[Anonymous], 2010, EUR PHARM
[4]  
[Anonymous], 2009, US PHARM
[5]  
[Anonymous], 2009, US PHARM, V701, P266
[6]  
Braidotti L, 1974, TECNICA FARMACEUTICA
[7]  
Camarco W., 2006, Journal of Pharmaceutical Technology, P28
[8]  
Casadio S., 1972, TECNOLOGIA FARMACEUT, V2a
[9]  
CREMER K, 2003, PHARM TECHNOL, V27, P22
[10]   Predicting orally disintegrating tablets formulations of ibuprophen tablets: An application of the new SeDeM-ODT expert system [J].
Edward Aguilar-Diaz, Johnny ;
Garcia-Montoya, Encarna ;
Maria Sune-Negre, Jose ;
Perez-Lozano, Pilar ;
Minarro, Montserrat ;
Ramon Tico, Jose .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2012, 80 (03) :638-648